Kakkis Emil D
Reporting Owner SEC Filing List

CIK: 0001248093
FormFilerSubject CompanyFiling AgentDateActions
4Statement of changes in beneficial owner...Ultragenyx Pharmaceutical Inc.Donnelley Financial Solutions /fa/04/20/2026
4Statement of changes in beneficial owner...Kakkis Emil DDonnelley Financial Solutions /fa/04/20/2026
4Statement of changes in beneficial owner...Ultragenyx Pharmaceutical Inc.Donnelley Financial Solutions /fa/03/03/2026
4Statement of changes in beneficial owner...Kakkis Emil DDonnelley Financial Solutions /fa/03/03/2026
4Statement of changes in beneficial owner...Ultragenyx Pharmaceutical Inc.Donnelley Financial Solutions /fa03/04/2025
4Statement of changes in beneficial owner...Kakkis Emil DDonnelley Financial Solutions /fa03/04/2025
144Filing for proposed sale of securities u...Ultragenyx Pharmaceutical Inc.Merrill Lynch Inc./operations/fa02/28/2025
144Filing for proposed sale of securities u...Kakkis Emil DMerrill Lynch Inc./operations/fa02/28/2025
4Statement of changes in beneficial owner...Ultragenyx Pharmaceutical Inc.Donnelley Financial Solutions /fa12/31/2024
4Statement of changes in beneficial owner...Kakkis Emil DDonnelley Financial Solutions /fa12/31/2024
Load More

Kakkis Emil D 's Ownership Transactions

IssuerFiling
Date
Transaction
Date
Transaction
Type
SharesPriceTotal AmtShares Owned